These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9191886)

  • 1. A primatized MAb to human CD4 causes receptor modulation, without marked reduction in CD4+ T cells in chimpanzees: in vitro and in vivo characterization of a MAb (IDEC-CE9.1) to human CD4.
    Anderson D; Chambers K; Hanna N; Leonard J; Reff M; Newman R; Baldoni J; Dunleavy D; Reddy M; Sweet R; Truneh A
    Clin Immunol Immunopathol; 1997 Jul; 84(1):73-84. PubMed ID: 9191886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4.
    Reddy MP; Kinney CA; Chaikin MA; Payne A; Fishman-Lobell J; Tsui P; Dal Monte PR; Doyle ML; Brigham-Burke MR; Anderson D; Reff M; Newman R; Hanna N; Sweet RW; Truneh A
    J Immunol; 2000 Feb; 164(4):1925-33. PubMed ID: 10657642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of metabolically radiolabeled CE9.1--a macaque-human chimeric anti-human CD4 monoclonal antibody--in transgenic mice bearing human CD4.
    Davis CB; Garver EM; Kwok DC; Urbanski JJ
    Drug Metab Dispos; 1996 Sep; 24(9):1032-7. PubMed ID: 8886616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous bioavailability of a PRIMATIZED IgG1 anti-human CD4 monoclonal antibody is dose dependent in transgenic mice bearing human CD4.
    Davis CB; Bugelski PJ
    Drug Deliv; 1998; 5(2):95-100. PubMed ID: 19570000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees.
    Newman R; Hariharan K; Reff M; Anderson DR; Braslawsky G; Santoro D; Hanna N; Bugelski PJ; Brigham-Burke M; Crysler C; Gagnon RC; Dal Monte P; Doyle ML; Hensley PC; Reddy MP; Sweet RW; Truneh A
    Clin Immunol; 2001 Feb; 98(2):164-74. PubMed ID: 11161972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunologic effects of a PRIMATIZED anti-CD4 monoclonal antibody in active rheumatoid arthritis: results of a phase I, single dose, dose escalating trial.
    Yocum DE; Solinger AM; Tesser J; Gluck O; Cornett M; O'Sullivan F; Nordensson K; Dallaire B; Shen CD; Lipani J
    J Rheumatol; 1998 Jul; 25(7):1257-62. PubMed ID: 9676753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo treatment with a monoclonal chimeric anti-CD4 antibody results in prolonged depletion of circulating CD4+ cells in chimpanzees.
    Jonker M; Slingerland W; Treacy G; van Eerd P; Pak KY; Wilson E; Tam S; Bakker K; Lobuglio AF; Rieber P
    Clin Exp Immunol; 1993 Sep; 93(3):301-7. PubMed ID: 8103714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8+ T cells lyse autologous monocytes in the presence of anti-CD3 monoclonal antibody: association with interleukin-1 production.
    Itoh K; Balch CM; Trial J; Platsoucas CD
    Cell Immunol; 1988 Jul; 114(2):257-71. PubMed ID: 3260540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A humanized anti-CD3 antibody, HuM291, with low mitogenic activity, mediates complete and reversible T-cell depletion in chimpanzees.
    Hsu DH; Shi JD; Homola M; Rowell TJ; Moran J; Levitt D; Druilhet B; Chinn J; Bullock C; Klingbeil C
    Transplantation; 1999 Aug; 68(4):545-54. PubMed ID: 10480415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humanized IgG1 and IgG4 anti-CD4 monoclonal antibodies: effects on lymphocytes in the blood, lymph nodes, and renal allografts in cynomolgus monkeys.
    Mourad GJ; Preffer FI; Wee SL; Powelson JA; Kawai T; Delmonico FL; Knowles RW; Cosimi AB; Colvin RB
    Transplantation; 1998 Mar; 65(5):632-41. PubMed ID: 9521196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule.
    Troadec S; Bès C; Chentouf M; Nguyen B; Briant L; Jacquet C; Chebli K; Pugnière M; Roquet F; Cerutti M; Chardès T
    Clin Immunol; 2006 Apr; 119(1):38-50. PubMed ID: 16426893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential functional effects of a humanized anti-CD4 antibody on resting and activated human T cells.
    Brett SJ; Rowan W; Smith M; Bartholomew M; Tite JP
    Immunology; 1997 Jul; 91(3):346-53. PubMed ID: 9301522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A humanized anti-human CD154 monoclonal antibody blocks CD154-CD40 mediated human B cell activation.
    Brams P; Black A; Padlan EA; Hariharan K; Leonard J; Chambers-Slater K; Noelle RJ; Newman R
    Int Immunopharmacol; 2001 Feb; 1(2):277-94. PubMed ID: 11360929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma.
    Kon OM; Sihra BS; Loh LC; Barkans J; Compton CH; Barnes NC; Larché M; Kay AB
    Eur Respir J; 2001 Jul; 18(1):45-52. PubMed ID: 11510804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of administration of a human anti-CD4 monoclonal antibody, HM6G, in nonhuman primates.
    Fishwild DM; Hudson DV; Deshpande U; Kung AH
    Clin Immunol; 1999 Aug; 92(2):138-52. PubMed ID: 10444358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 mAb induced apoptosis of peripheral T cells: multiparameter subpopulation analysis by flow cytometry using Attractors.
    Fishman-Lobell J; Tsui P; Reddy M; DiPrinzio R; Eichman C; Sweet RW; Truneh A
    J Immunol Methods; 2001 Nov; 257(1-2):71-82. PubMed ID: 11687240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of cell surface CD4 molecule expression induced by anti-CD4 antibodies in human T lymphocytes.
    Morel P; Vincent C; Wijdenes J; Revillard JP
    Cell Immunol; 1992 Dec; 145(2):287-98. PubMed ID: 1451179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of T-cell subsets in the response to anti-CD3 monoclonal antibodies.
    Finck BK; Yung CM; Carteron NL; Wofsy D
    Clin Immunol Immunopathol; 1992 Dec; 65(3):234-41. PubMed ID: 1360341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antitumoral activity of baculovirus-expressed chimeric recombinant anti-CD4 antibody 13B8.2 on T-cell lymphomas.
    Troadec S; Chentouf M; Cérutti M; Nguyen B; Olive D; Bès C; Chardès T
    J Immunother; 2007; 30(2):190-202. PubMed ID: 17471166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.